Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2017
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis
Lien Bekaert, Samuel Valable, Emmanuèle Lechapt-Zalcman, et al.
European Journal of Neurology
|
October 26, 2020
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
Céline Louapre, Elisabeth Maillart, Caroline Papeix, et al.
Neurology and Therapy
|
February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
Juliette Pelle, Anais R Briant, Pierre Branger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 12, 2024
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis
Géraldine Androdias, Louise Noroy, Dimitri Psimaras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 22, 2023
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
Sara Carta, Alessandro Dinoto, Marco Capobianco, et al.
Journal of Neuroimmunology
|
April 22, 2024
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies
Lucia Campetella, Macarena Villagrán-García, Antonio Farina, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
BMC Neurology
|
October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
Neurology
|
April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
Apolline Tournier, Antoine Gavoille, Julie Pique, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
European Journal of Nuclear Medicine and Molecular Imaging
|
March 20, 2017
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis
Lien Bekaert, Samuel Valable, Emmanuèle Lechapt-Zalcman, et al.
European Journal of Neurology
|
October 26, 2020
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
Céline Louapre, Elisabeth Maillart, Caroline Papeix, et al.
Neurology and Therapy
|
February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
Juliette Pelle, Anais R Briant, Pierre Branger, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 12, 2024
Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis
Géraldine Androdias, Louise Noroy, Dimitri Psimaras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
December 22, 2023
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
Sara Carta, Alessandro Dinoto, Marco Capobianco, et al.
Journal of Neuroimmunology
|
April 22, 2024
Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies
Lucia Campetella, Macarena Villagrán-García, Antonio Farina, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
BMC Neurology
|
October 28, 2025
Influence of geographical accessibility to specialist and primary care givers on excess mortality of multiple sclerosis patients in France
Sarah Wilson, Emmanuelle Leray, Floriane Calocer, et al.
Neurology
|
April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS
Apolline Tournier, Antoine Gavoille, Julie Pique, et al.
Page
of 3